Pfizer Awards Grant to UC Riverside Researchers for Discovery of IBD Therapeutic Target

Pfizer Awards Grant to UC Riverside Researchers for Discovery of IBD Therapeutic Target
Pfizer has awarded $150,000 to Declan McCole, PhD, and his team to find a therapeutic target for correcting intestinal barrier defects for patients with inflammatory bowel disease (IBD) who have mutations in the T-cell protein tyrosine phosphatase (TCPTP) protein. TCPTP, which plays a key role in IBD, protects the intestinal epithelial barrier function and is encoded by a

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *